MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

Description

This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment

Conditions

Neoplasms Prostate, Cancer of the Prostate

Talk to us

Study Overview

On this page

Study Details

Study overview

This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment

Office Based MRI/Ultrasound Guided Prostate Cancer Ablation: Outcomes Registry

MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

Condition
Neoplasms Prostate
Intervention / Treatment

-

Contacts and Locations

Miami Lakes

Urological Research Network, Miami Lakes, Florida, United States, 33016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men between 50 and 65 years of age with a clinical diagnosis of prostate cancer with Low or Intermediate risk prostate cancer, and \<50% positive core rate by prostate lobe
  • * Men older than 65 years of age with clinical diagnosis of prostate cancer \<50% positive core rate by prostate lobe
  • * Absence of extra-capsular extension
  • * Absence of seminal vesicle invasion
  • * Absence of regional or distant metastatic disease
  • * Multiparametric MRI of the prostate performed either before the biopsy or \>10 weeks after prostate biopsy
  • * Treated with Cryotherapy of the prostate
  • * Treatment based on co-registration between MP-MRI and Prostate Ultrasound
  • * Prior treatment of prostate cancer in the form of surgery.
  • * Performance status greater than 0 based on ECOG criteria
  • * Mental status impairment

Ages Eligible for Study

50 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Urological Research Network, LLC,

FERNANDO J BIANCO, MD, PRINCIPAL_INVESTIGATOR, UROLOGICAL RESEARCH NETWORK

EUSEBIO LUNA, MD, STUDY_DIRECTOR, UROLOGICAL RESEARCH NETWORK

Isabel H Lopez, MD, STUDY_DIRECTOR, UROLOGICAL RESEARCH NETWORK

Study Record Dates

2038-11